Oliver Bisazza is the CEO of MedTech Europe.

With a background in EU policy and regulatory leadership, Oliver has played a key role in shaping Europe’s medtech landscape, now focused on strengthening competitiveness, advancing regulation, and improving patient access to innovation.

Oliver has watched this industry from the inside for nearly 20 years. He's lived through the MDR chaos, the pandemic, the talent drought, and the moment European politicians finally started asking what do we need to do to keep you here?

In this episode, Oliver Bisazza joins us to discuss “Is Europe still worth it for medtech companies?” We talk about how Europe’s medtech landscape is evolving, and why staying competitive globally is no longer guaranteed.

Tune in for:

• Why Europe’s attractiveness for medtech companies should not be taken for granted
• How sustainability can be a competitive edge.
• How to cut through “noise” and say no to the right things.
• What MDR & IVDR really taught the industry about public trust.
• How talent gaps and digital transformation are reshaping medtech.

Career inspiration, medtech opportunities, hiring solutions and market insights, all in one place. Find them here.

Unlock practical strategies for staying future-ready in MedTech! 🎙️

In this episode, we explore the skills and mindsets professionals need to thrive in 2026:

∘ What skills are essential to stay relevant in Regulatory & Quality roles?
∘ How is AI already reshaping hiring, team structures, and daily work?
∘ What are hiring managers prioritising right now, and how can you stand out?

Hosted by Elena Kyria, CEO of elemed, this session features industry experts:
🔹 Ahmed Salah - Consulting Director - elemed
🔹 Maarten ter Mors - CEO - Raiana.ai
🔹 Erik Vollebregt - Partner-Axon Lawyers, Board Member- Raiana.ai

Tune in for actionable insights, practical tips, and strategies you can apply immediately—whether you’re building expertise, leading a team, or navigating the changing MedTech landscape.

Career inspiration, medtech opportunities, hiring solutions and market insights, all in one place. Find them here.

With a background spanning Boston Consulting Group, Novartis and Silicon Valley, Michelle Wu is a leader at the forefront of AI in MedTech. Today, she’s the co-founder and CEO of NyquistAI and recognised as one of the top 100 women in AI globally.

Michelle believes that successful AI adoption has far less to do with the technology, and far more to do with people. Mindset, culture and clarity matter more than tools - and the companies who get this right will move fastest.

With a career shaped by data, strategy and innovation, Michelle offers an honest look at what AI can (and can’t) do for regulatory affairs, and how leaders can turn ambition into real impact.

Tune in for:

• Why 86% of leaders are struggling with AI
• The three factors every company needs for real adoption
• How to avoid AI fatigue and overload
• What AI will really change in regulatory careers
• Why mindset, structure and data matter more than hype
  And much more!

Want to build real GenAI capability in RA?

Apply for elemed’s AI Accelerator 2026: a focused programme where RA leaders pilot one workflow inside real work and measure the impact.

Request access 👉 https://www.elemed.eu/request-access-ai-accelerator/#request-form

Requests are reviewed and seats are limited.

Career inspiration, medtech opportunities, hiring solutions and market insights, all in one place. Find them here.